Consolidated Statements of Cash Flows (Parenthetical) (USD $)	Mar. 31, 2010	Mar. 23, 2005 Insert Therapeutics Inc	Feb. 28, 2010 Calando Pharmaceuticals Inc	Nov. 30, 2009 Calando Pharmaceuticals Inc	Mar. 31, 2006 Calando Pharmaceuticals Inc	Sep. 30, 2010 Calando Pharmaceuticals Inc Series A Preferred Stock	Apr. 20, 2007 Carbon Nanotechnologies Inc Series E Preferred Stock	Sep. 28, 2009 Unidym Inc	Apr. 23, 2008 Unidym Inc	Sep. 22, 2009 Unidym Inc Series A Preferred Stock	Jun. 11, 2009 Unidym Inc Series A Preferred Stock	Nov. 30, 2009 Unidym Inc Series C Preferred Stock	Jun. 25, 2009 Unidym Inc Series C Preferred Stock	Sep. 30, 2009 Unidym Inc Series C One Preferred Stock	Apr. 29, 2008 MASA Energy LLC	Oct. 21, 2011 Roche Madison
Purchase of common shares		7,375,000	200,000	2,850,000	964,000	1,562.5			200,000
Common stock, shares issued	12,870	50,226	8,000	114,000	20,838		143,122	64,227	7,054	9,149	132,462	15,317	194,444	27,777	10,504	1,288,158
Common stock value		$ 2,000,000		$ 706,800	$ 1,077,333		$ 5,400,000	$ 398,209		$ 46,662	$ 688,802	$ 47,485	$ 972,222	$ 186,111	$ 310,000
Value of common stock purchased					1,928,000										560,000
Stock purchased by cash			60,000		850,667				200,000						250,000
Warrants issued			2,400	24,000		390,625
Warrants purchased				600,000
Common stock exercise value			$ 5.00			$ 5.00
Warrants exercised	24,788
Issue of promissory note to Roche																$ 50,000